Cargando…
Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework
Primary sclerosing cholangitis (PSC) is a rare, immune-mediated, chronic cholestatic liver disease associated with a unique phenotype of inflammatory bowel disease that frequently manifests as pancolitis with right-sided predominance. Available data suggest a bidirectional interplay of the gut-liver...
Autores principales: | Shah, Ayesha, Macdonald, Graeme A., Morrison, Mark, Holtmann, Gerald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269024/ https://www.ncbi.nlm.nih.gov/pubmed/32250997 http://dx.doi.org/10.14309/ajg.0000000000000604 |
Ejemplares similares
-
How frequent are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin?
por: Shah, Ayesha, et al.
Publicado: (2022) -
Gut microbiome in primary sclerosing cholangitis: A review
por: Little, Rebecca, et al.
Publicado: (2020) -
Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022) -
Gut Microbiome of Children and Adolescents With Primary Sclerosing Cholangitis in Association With Ulcerative Colitis
por: Cortez, Ramon V., et al.
Publicado: (2021) -
Gut Inflammation in Primary Sclerosing Cholangitis and Autoimmune Sclerosing Cholangitis-Contrasting Pattern of Liver-gut Cross Talk
por: Navaneethan, Udayakumar
Publicado: (2015)